These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2810268)

  • 1. Criteria for assessing disease activity in systemic lupus erythematosus.
    Isenberg D; Bacon P; Bombardier C; Gladman D; Goldsmith CH; Kalunian K; Liang M; Maddison P; Nived O; Richter M
    J Rheumatol; 1989 Oct; 16(10):1395-6. PubMed ID: 2810268
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI; Feldman BM; Bombardier C; Silverman ED
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index.
    Davey R; Bamford J; Emery P
    Arthritis Rheum; 2007 Aug; 56(8):2812-3. PubMed ID: 17665430
    [No Abstract]   [Full Text] [Related]  

  • 6. Lupus activity criteria count.
    Schattner A
    J Rheumatol; 1985 Dec; 12(6):1203-4. PubMed ID: 3937897
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of disease activity in systemic lupus erythematosus].
    Kano S
    Ryumachi; 1996 Feb; 36(1):69-81. PubMed ID: 8711541
    [No Abstract]   [Full Text] [Related]  

  • 8. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus.
    Hawker G; Gabriel S; Bombardier C; Goldsmith C; Caron D; Gladman D
    J Rheumatol; 1993 Apr; 20(4):657-60. PubMed ID: 8496860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus disease severity in men and women: a case-control study.
    Aranow C; Del Guidice J; Barland P; Weinstein A
    J Rheumatol; 2002 Aug; 29(8):1674-7. PubMed ID: 12180728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe visceral disease in subacute cutaneous lupus erythematosus.
    Weinstein CL; Littlejohn GO; Thomson NM; Hall S
    Arch Dermatol; 1987 May; 123(5):638-40. PubMed ID: 3579344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to letter by Isenberg and Gordon commenting on the Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus.
    Ruperto N; Ravelli A; Martini A;
    Arthritis Rheum; 2006 Nov; 54(11):3723-4. PubMed ID: 17075891
    [No Abstract]   [Full Text] [Related]  

  • 15. Instruments to measure disease activity in systemic lupus erythematosus -- is our net tight enough to catch the hydra?
    Sturfelt G; Nived O
    J Rheumatol; 2011 Jan; 38(1):3-4. PubMed ID: 21196581
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic lupus erythematosus activity. An operational definition.
    Liang MH; Stern S; Esdaile JM
    Rheum Dis Clin North Am; 1988 Apr; 14(1):57-66. PubMed ID: 3135558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity or inactivity: is this the question in systemic lupus erythematosus?].
    Cervera R; Font J
    Med Clin (Barc); 1993 Sep; 101(7):255-7. PubMed ID: 7746000
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus].
    Robak E; Kwiecień A; Sysa-Jedrzejowska A
    Przegl Lek; 2005; 62(5):299-305. PubMed ID: 16334536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
    Ruperto N; Buratti S; Duarte-Salazar C; Pistorio A; Reiff A; Bernstein B; Maldonado-Velázquez MR; Beristain-Manterola R; Maeno N; Takei S; Falcini F; Lepore L; Spencer CH; Pratsidou-Gertsi P; Martini A; Ravelli A
    Arthritis Rheum; 2004 Jun; 51(3):458-64. PubMed ID: 15188334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.